| - GRCh37:
- Chr11:128709778
- GRCh38:
- Chr11:128839883
| KCNJ1 | V121M, V138M, V140M | Bartter disease type 2 | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr11:128710147
- GRCh38:
- Chr11:128840252
| KCNJ1 | T15A, T17A | Bartter disease type 2 | Uncertain significance (Jun 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128710059
- GRCh38:
- Chr11:128840164
| KCNJ1 | D27G, D44G, D46G | Bartter disease type 2 | Uncertain significance (Jun 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128709019
- GRCh38:
- Chr11:128839124
| KCNJ1 | | Bartter disease type 2 | Uncertain significance (May 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128709626
- GRCh38:
- Chr11:128839731
| KCNJ1 | K171N, K188N, K190N | Bartter disease type 2 | Uncertain significance (Oct 19, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128709837
- GRCh38:
- Chr11:128839942
| KCNJ1 | P101L, P118L, P120L | Bartter disease type 2 | Uncertain significance (Oct 19, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128709888
- GRCh38:
- Chr11:128839993
| KCNJ1 | A101V, A103V, A84V | Bartter disease type 2 | Likely pathogenic (Jun 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128712281
- GRCh38:
- Chr11:128842386
| KCNJ1 | T11M | not provided, Bartter disease type 2 | Uncertain significance (Mar 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:128709120
- GRCh38:
- Chr11:128839225
| KCNJ1 | L359R, L357R, L340R | Inborn genetic diseases, not provided, Bartter disease type 2
| Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:128709841
- GRCh38:
- Chr11:128839946
| KCNJ1 | T119A, T117A, T100A | Inborn genetic diseases, not provided, Bartter disease type 2
| Uncertain significance (Jul 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:128710105
- GRCh38:
- Chr11:128840210
| KCNJ1 | R12C, R31C, R29C | not provided, Bartter disease type 2 | Uncertain significance (Oct 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:128709633
- GRCh38:
- Chr11:128839738
| KCNJ1 | R169H, R186H, R188H | not provided, Bartter disease type 2 | Uncertain significance (May 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:128709138
- GRCh38:
- Chr11:128839243
| KCNJ1 | P334fs, P351fs, P353fs | Bartter disease type 2 | Uncertain significance (Jan 22, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128709589
- GRCh38:
- Chr11:128839694
| KCNJ1 | R184W, R201W, R203W | Bartter disease type 2 | Likely pathogenic (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128709634
- GRCh38:
- Chr11:128839739
| KCNJ1 | R169S, R186S, R188S | not provided, Bartter disease type 2 | Uncertain significance (Jan 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:128709297
- GRCh38:
- Chr11:128839402
| KCNJ1 | T281R, T298R, T300R | Bartter disease type 2 | Uncertain significance (Jun 26, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128709867
- GRCh38:
- Chr11:128839972
| KCNJ1 | P108L, P110L, P91L | Bartter disease type 2 | Likely pathogenic (Jul 19, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:128709023
- GRCh38:
- Chr11:128839128
| KCNJ1 | M389I, M372I, M391I | Bartter disease type 2, not provided | Uncertain significance (May 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:128710052
- GRCh38:
- Chr11:128840157
| KCNJ1 | | Bartter disease type 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128709983
- GRCh38:
- Chr11:128840088
| KCNJ1 | | Bartter disease type 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128709618
- GRCh38:
- Chr11:128839723
| KCNJ1 | T193M, T191M, T174M | Bartter disease type 2, not provided | Conflicting interpretations of pathogenicity (Sep 12, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:128709433
- GRCh38:
- Chr11:128839538
| KCNJ1 | A236T, A253T, A255T | Bartter disease type 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128708283
- GRCh38:
- Chr11:128838388
| KCNJ1 | | Bartter disease type 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128708219
- GRCh38:
- Chr11:128838324
| KCNJ1 | | Bartter disease type 2 | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128708156
- GRCh38:
- Chr11:128838261
| KCNJ1 | | Bartter disease type 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128708052
- GRCh38:
- Chr11:128838157
| KCNJ1 | | Bartter disease type 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128709341
- GRCh38:
- Chr11:128839446
| KCNJ1 | | Bartter disease type 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128709297
- GRCh38:
- Chr11:128839402
| KCNJ1 | T300I, T298I, T281I | Bartter disease type 2, not provided | Uncertain significance (Jul 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:128709193
- GRCh38:
- Chr11:128839298
| KCNJ1 | G333R, G335R, G316R | Bartter disease type 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128710112
- GRCh38:
- Chr11:128840217
| KCNJ1 | | Bartter disease type 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128708937
- GRCh38:
- Chr11:128839042
| KCNJ1 | | Bartter disease type 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128709538
- GRCh38:
- Chr11:128839643
| KCNJ1 | L218F, L220F, L201F | Bartter syndrome, not provided, Bartter disease type 2
| Conflicting interpretations of pathogenicity (Mar 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:128709537
- GRCh38:
- Chr11:128839642
| KCNJ1 | L220R, L201R, L218R | Bartter disease type 2 | Likely pathogenic (Jul 1, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128709588
- GRCh38:
- Chr11:128839693
| KCNJ1 | R201Q, R203Q, R184Q | Bartter disease type 2 | Likely pathogenic (Jul 1, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128709561
- GRCh38:
- Chr11:128839666
| KCNJ1 | R193P, R212P, R210P | Bartter disease type 2, not provided | Uncertain significance (Mar 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:128712297
- GRCh38:
- Chr11:128842402
| KCNJ1 | R6W | not provided, Bartter disease type 2 | Uncertain significance (Apr 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:128709887
- GRCh38:
- Chr11:128839992
| KCNJ1 | | not provided, Bartter disease type 2 | Benign/Likely benign (Oct 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:128709341
- GRCh38:
- Chr11:128839446
| KCNJ1 | | Bartter disease type 2, not provided | Conflicting interpretations of pathogenicity (Aug 26, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:128709635
- GRCh38:
- Chr11:128839740
| KCNJ1 | K168fs, K185fs, K187fs | Bartter disease type 2 | Likely pathogenic (Sep 19, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128709984
- GRCh38:
- Chr11:128840089
| KCNJ1 | T52M, T71M, T69M | not provided, Bartter syndrome, Bartter disease type 2
| Conflicting interpretations of pathogenicity (Mar 24, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:128709513
- GRCh38:
- Chr11:128839618
| KCNJ1 | G209E, G228E, G226E | Bartter disease type 2 | Uncertain significance (Sep 7, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128709272
- GRCh38:
- Chr11:128839377
| KCNJ1 | C289*, C308*, C306* | Bartter disease type 2, not provided | Pathogenic/Likely pathogenic (May 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:128709184
- GRCh38:
- Chr11:128839289
| KCNJ1 | R319*, R338*, R336* | not provided, Bartter disease type 2 | Likely pathogenic (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:128709434
- GRCh38:
- Chr11:128839539
| KCNJ1 | | not specified, not provided, Bartter disease type 2
| Conflicting interpretations of pathogenicity (Oct 10, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:128712280
- GRCh38:
- Chr11:128842385
| KCNJ1 | | not specified, not provided, Bartter disease type 2
| Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:128709877
- GRCh38:
- Chr11:128839982
| KCNJ1 | K88*, K107*, K105* | Bartter disease type 2 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr11:128712417
- GRCh38:
- Chr11:128842522
| KCNJ1 | | Bartter disease type 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128712356
- GRCh38:
- Chr11:128842461
| KCNJ1 | | Bartter disease type 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128712326
- GRCh38:
- Chr11:128842431
| KCNJ1 | | Bartter disease type 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128710122
- GRCh38:
- Chr11:128840227
| KCNJ1 | R25Q, R6Q, R23Q | Bartter disease type 2, not provided | Conflicting interpretations of pathogenicity (Sep 29, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:128710104
- GRCh38:
- Chr11:128840209
| KCNJ1 | R12H, R31H, R29H | Bartter disease type 2, not provided | Conflicting interpretations of pathogenicity (Jul 6, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:128709571
- GRCh38:
- Chr11:128839676
| KCNJ1 | L190F, L209F, L207F | Bartter disease type 2, not provided | Likely benign (Mar 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:128709562
- GRCh38:
- Chr11:128839667
| KCNJ1 | R193*, R212*, R210* | Bartter disease type 2 | Conflicting interpretations of pathogenicity (Sep 9, 2020) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:128709407
- GRCh38:
- Chr11:128839512
| KCNJ1 | | Bartter disease type 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128709347
- GRCh38:
- Chr11:128839452
| KCNJ1 | | Bartter disease type 2, not provided | Benign/Likely benign (Jun 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:128709302
- GRCh38:
- Chr11:128839407
| KCNJ1 | | Bartter disease type 2, not provided | Conflicting interpretations of pathogenicity (Jul 9, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:128709216
- GRCh38:
- Chr11:128839321
| KCNJ1 | P308L, P327L, P325L | Bartter disease type 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128709004
- GRCh38:
- Chr11:128839109
| KCNJ1 | | Bartter disease type 2, not provided | Likely benign (Feb 3, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:128708932
- GRCh38:
- Chr11:128839037
| KCNJ1 | | Bartter disease type 2 | Likely benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128708672
- GRCh38:
- Chr11:128838777
| KCNJ1 | | Bartter disease type 2 | Benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128708638
- GRCh38:
- Chr11:128838743
| KCNJ1 | | Bartter disease type 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128708568
- GRCh38:
- Chr11:128838673
| KCNJ1 | | Bartter disease type 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128708513
- GRCh38:
- Chr11:128838618
| KCNJ1 | | Bartter disease type 2 | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128708467
- GRCh38:
- Chr11:128838572
| KCNJ1 | | Bartter disease type 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128708056
- GRCh38:
- Chr11:128838161
| KCNJ1 | | Bartter disease type 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128709105
- GRCh38:
- Chr11:128839210
| KCNJ1 | D345G, D362G, D364G | Inborn genetic diseases, not provided, Bartter disease type 2
| Uncertain significance (May 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:128709634
- GRCh38:
- Chr11:128839739
| KCNJ1 | R169C, R188C, R186C | not specified, Bartter disease type 2, Inborn genetic diseases, not provided | Conflicting interpretations of pathogenicity (Sep 7, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:128709877
- GRCh38:
- Chr11:128839982
| KCNJ1 | K88E, K107E, K105E | Bartter disease type 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:128709897
- GRCh38:
- Chr11:128840002
| KCNJ1 | Y81C, Y100C, Y98C | not provided, Bartter disease type 2 | Uncertain significance (Apr 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:128709824
- GRCh38:
- Chr11:128839929
| KCNJ1 | N105K, N124K, N122K | Bartter disease type 2 | Pathogenic (Sep 11, 1998) | no assertion criteria provided |
| - GRCh37:
- Chr11:128709874
- GRCh38:
- Chr11:128839979
| KCNJ1 | D108H, D89H, D106H | Bartter disease type 2 | Pathogenic (Jan 23, 1997) | no assertion criteria provided |
| - GRCh37:
- Chr11:128709696
- GRCh38:
- Chr11:128839801
| KCNJ1 | G167E, G148E, G165E | Bartter disease type 2 | Pathogenic (Jan 1, 1997) | no assertion criteria provided |
| - GRCh37:
- Chr11:128709604
- GRCh38:
- Chr11:128839709
| KCNJ1 | A198T, A179T, A196T | Bartter disease type 2 | Pathogenic (Jan 1, 1997) | no assertion criteria provided |
| - GRCh37:
- Chr11:128709126
- GRCh38:
- Chr11:128839231
| KCNJ1 | M338T, M355T, M357T | not specified, not provided | Benign/Likely benign (Oct 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:128709555
- GRCh38:
- Chr11:128839660
| KCNJ1 | A195V, A212V, A214V | Bartter disease type 2 | Likely pathogenic (Mar 14, 2022) | criteria provided, single submitter |
| | KCNJ1 | | Bartter disease type 2 | Pathogenic (Oct 1, 1996) | no assertion criteria provided |
| - GRCh37:
- Chr11:128709539
- GRCh38:
- Chr11:128839644
| KCNJ1 | S200R, S219R, S217R | Bartter disease type 2 | Pathogenic (Jun 1, 1998) | no assertion criteria provided |
| - GRCh37:
- Chr11:128710096-128710097
- GRCh38:
- Chr11:128840201-128840202
| KCNJ1 | G15fs, G32fs, G34fs | Bartter disease type 2 | Pathogenic (Oct 1, 1996) | no assertion criteria provided |
| - GRCh37:
- Chr11:128709959
- GRCh38:
- Chr11:128840064
| KCNJ1 | Y60*, Y77*, Y79* | Bartter disease type 2 | Pathogenic (Oct 1, 1996) | no assertion criteria provided |